{
    "title": "107_hr5204",
    "content": "The Act may be cited as the \"Hormone Replacement Therapy Alternative Treatment Fairness Act\" and includes a table of contents. The \"Hormone Replacement Therapy Alternative Treatment Fairness Act\" includes provisions for Medicare, Medicaid, group health plans, individual health insurance, FEHBP, veterans' benefits, and TRICARE to cover hormone replacement therapy and alternative treatments. Key findings are also outlined in the Act. Congress finds that 50 million women in the United States suffer from menopause-related symptoms, including osteoporosis, hot flashes, heart disease, and depression. The Women's Health Initiative ended its study on synthetic hormone replacement therapy (HRT) early due to increased risks of heart disease, stroke, blood clots, and breast cancer. Only 35 percent of menopausal women in the US take prescribed synthetic HRT, while natural estrogen and progestin could be beneficial for treating symptoms. 33 percent of menopausal women in the US use alternative treatments like Soy, Black Cohosh, Chasteberry, Pro-Gest, Hops, Red Clover, Dong Quai, Evening Primose Oil, Vitamin E, Flax Seed Oil, Ginseng, and natural DHEA. Government insurance programs and most private insurance do not cover non-prescription alternative HRT treatments. \"Medicare coverage for hormone replacement therapy and alternative treatments\" The Social Security Act is amended to include hormone replacement therapy and alternative treatments for menopausal symptoms, recommended by a licensed healthcare provider and proven safe and effective in scientific studies. The amendments apply to therapies provided after the enactment of the Act. MEDICAID COVERAGE OF ALTERNATIVE TREATMENTS FOR HORMONE REPLACEMENT THERAPY. Medicaid coverage is expanded to include alternative therapy for hormone replacement therapy for menopausal symptoms. This amendment adds the new therapy as paragraph (27) under Section 1905(a) of the Social Security Act. Medicaid coverage is expanded to include alternative therapy for hormone replacement therapy for menopausal symptoms, recommended by a licensed health care provider and proven safe and effective in scientific studies. The amendments apply to therapies furnished on or after the enactment date of the Act. SEC. 5 of the Act expands coverage of hormone replacement therapy and alternative treatments under group health plans and individual health insurance coverage. Medicaid now includes alternative therapy for menopausal symptoms, recommended by a licensed health care provider and proven safe and effective in scientific studies. The Act expands coverage for hormone replacement therapy and alternative treatments for menopausal symptoms under group health plans and individual health insurance coverage. Hormone replacement therapy benefits cannot be excluded or restricted, and alternative therapies recommended by a healthcare provider are now included in coverage. The Act requires group health plans to cover therapies recommended by licensed providers proven safe and effective in scientific studies. It also amends sections of the Employee Retirement Income Security Act to include these requirements. The Act mandates group health plans to cover hormone replacement therapy and alternative treatments recommended by licensed providers. The Act requires group health plans to cover hormone replacement therapy and alternative treatments for menopausal symptoms recommended by healthcare providers. The Act mandates group health plans to cover hormone replacement therapy and alternative treatments for menopausal symptoms recommended by licensed healthcare providers, proven safe and effective in scientific studies. It also requires notice of this requirement as a material modification in the plan terms. The Act is amended to include sections 711 and 714, and the table of contents is updated to reflect this change. Sec. 714 of the Act amends the Internal Revenue Code of 1986 to include coverage of hormone replacement therapy and alternative treatments. Sec. 9813 introduces a standard for coverage of hormone replacement therapy and alternative treatments. Group health plans must cover hormone replacement therapy for menopausal symptoms and cannot exclude alternative therapies recommended by licensed healthcare providers if proven safe and effective in scientific studies. The Code is amended to include sections 9811 and 9813. Part B of title XXVII of the Public Health Service Act is amended to add a new section after section 2752. The Code is amended to include sections 9811 and 9813, adding a new section after section 2752 regarding standard relating to coverage of hormone replacement therapy and alternative treatments. The provisions of section 2707(a) apply to health insurance coverage in the individual market. Health insurance issuers must comply with notice requirements similar to those for group health plans. Section 2762(b)(2) is amended to include additional sections. These amendments apply to therapies provided after the enactment of this Act. The Secretaries of Labor, Treasury, and Health and Human Services must coordinate regulations, rulings, and interpretations to ensure consistent enforcement and avoid duplication of efforts in administering therapies under this Act. SEC. 6. Coverage of hormone replacement therapy and alternative treatments under FEHBP. Section 8902 of title 5, United States Code, is amended to include coverage for hormone replacement therapy for menopausal symptoms in health plans. Alternative therapies recommended by licensed healthcare providers and proven safe and effective in studies must also be covered. The amendment made by this section applies to contracts and plans approved after the enactment of this Act. SEC. 7 amends Section 1701(6) of title 38, United States Code to include coverage of alternative hormone replacement therapy for menopausal symptoms if recommended by a licensed health care provider and proven safe and effective. SEC. 8 extends coverage of alternative hormone replacement therapy under TRICARE. TRICARE program will now cover alternative hormone replacement therapy for menopausal symptoms if recommended by a licensed health care provider and proven safe and effective in scientific studies. TRICARE program will cover alternative hormone replacement therapy for menopausal symptoms as of the enactment of this Act."
}